Elevance Health (ELV) reported Q2 2025 financial results before market open.
The company posted revenue of $49.42 billion, surpassing estimates of $48.23 billion by 2.5% and marking a 14.3% increase compared to $43.22 billion a year ago.
Adjusted earnings came in at $8.84 per share, below the estimate of $9.20 and down 12.6% from $10.12 in the prior year. For FY 2025, the earnings outlook was revised to a range of $34.15 to $34.85 from a prior $30.00, slightly above the estimate of $34.40.
Earnings Insight
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/17/2025 | BMO | ELV | Elevance Health | Q2 2025 | EPS | 9.20 | 8.84 | -3.91 | 10.12 | -12.60 | Healthcare / Healthcare Plans |
| 04/22/2025 | BMO | ELV | Elevance Health | Q1 2025 | EPS | 11.38 | 11.97 | 5.18 | 10.64 | 12.50 | Healthcare / Healthcare Plans |
| 01/23/2025 | BMO | ELV | Elevance Health | Q4 2024 | EPS | 10.62 | 3.84 | -63.84 | 5.62 | -31.70 | Healthcare / Healthcare Plans |
| 10/17/2024 | BMO | ELV | Elevance Health | Q3 2024 | EPS | 9.66 | 8.37 | -13.35 | 8.99 | -6.90 | Healthcare / Healthcare Plans |
| 07/17/2024 | BMO | ELV | Elevance Health | Q2 2024 | EPS | 10.01 | 10.12 | 1.10 | 9.04 | 11.90 | Healthcare / Healthcare Plans |
